PMC:7096775 / 8612-10004
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":1281,"end":1290},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma74591"}],"text":"Ventilation\nThree case series from the province Hubei described a high rate of cases who needed ventilation (20%, 23% and 25%) [5,6,10]. German pneumonia patients had a two- to threefold lower ventilation rate of 9%. The two case series from Shenzhen and the province Zhejiang also reported much lower ventilation rates of, respectively, 11% and 2% [9,11] (Figure 2). The median duration of ventilation was 9 days (interquartile range: 7–19, n = 13) for non-invasive and 17 days (interquartile range: 12–19, n = 4) for invasive ventilation in the COVID-19 case series described by Chen et al. [5]. In contrast, the median ventilation duration (invasive and non-invasive) in SPP was only 2 days (interquartile range: 1–4, n = 303). The high ventilation rates and the long duration of ventilation (data from one case series) can be attributed to a high rate of acute respiratory distress syndrome (ARDS) among COVID-19 patients. Again, the difference between Hubei (17–20% ARDS) and outside of Hubei (2–4% ARDS) is striking. However, ARDS was observed in only 1% of SPP.\nFigure 2 Reported proportions of patients on ventilation and proportions of patients who were still hospitalised, five COVID-19 case series, China, January–February 2020 (n = 734)\nCOVID-19: coronavirus disease.\nGrey line: proportion of ventilation in pneumonia sentinel patients. Data from five COVID-19 series [5,6,9-11]."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T66","span":{"begin":144,"end":153},"obj":"Disease"},{"id":"T67","span":{"begin":547,"end":555},"obj":"Disease"},{"id":"T68","span":{"begin":859,"end":894},"obj":"Disease"},{"id":"T69","span":{"begin":865,"end":894},"obj":"Disease"},{"id":"T70","span":{"begin":896,"end":900},"obj":"Disease"},{"id":"T71","span":{"begin":908,"end":916},"obj":"Disease"},{"id":"T72","span":{"begin":971,"end":975},"obj":"Disease"},{"id":"T73","span":{"begin":1004,"end":1008},"obj":"Disease"},{"id":"T74","span":{"begin":1032,"end":1036},"obj":"Disease"},{"id":"T75","span":{"begin":1189,"end":1197},"obj":"Disease"},{"id":"T76","span":{"begin":1250,"end":1258},"obj":"Disease"},{"id":"T77","span":{"begin":1321,"end":1330},"obj":"Disease"},{"id":"T78","span":{"begin":1365,"end":1373},"obj":"Disease"}],"attributes":[{"id":"A66","pred":"mondo_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A67","pred":"mondo_id","subj":"T67","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A68","pred":"mondo_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A69","pred":"mondo_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A71","pred":"mondo_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A75","pred":"mondo_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Ventilation\nThree case series from the province Hubei described a high rate of cases who needed ventilation (20%, 23% and 25%) [5,6,10]. German pneumonia patients had a two- to threefold lower ventilation rate of 9%. The two case series from Shenzhen and the province Zhejiang also reported much lower ventilation rates of, respectively, 11% and 2% [9,11] (Figure 2). The median duration of ventilation was 9 days (interquartile range: 7–19, n = 13) for non-invasive and 17 days (interquartile range: 12–19, n = 4) for invasive ventilation in the COVID-19 case series described by Chen et al. [5]. In contrast, the median ventilation duration (invasive and non-invasive) in SPP was only 2 days (interquartile range: 1–4, n = 303). The high ventilation rates and the long duration of ventilation (data from one case series) can be attributed to a high rate of acute respiratory distress syndrome (ARDS) among COVID-19 patients. Again, the difference between Hubei (17–20% ARDS) and outside of Hubei (2–4% ARDS) is striking. However, ARDS was observed in only 1% of SPP.\nFigure 2 Reported proportions of patients on ventilation and proportions of patients who were still hospitalised, five COVID-19 case series, China, January–February 2020 (n = 734)\nCOVID-19: coronavirus disease.\nGrey line: proportion of ventilation in pneumonia sentinel patients. Data from five COVID-19 series [5,6,9-11]."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T59","span":{"begin":64,"end":65},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T60","span":{"begin":167,"end":168},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T61","span":{"begin":338,"end":340},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T62","span":{"begin":844,"end":845},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T63","span":{"begin":1388,"end":1390},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"Ventilation\nThree case series from the province Hubei described a high rate of cases who needed ventilation (20%, 23% and 25%) [5,6,10]. German pneumonia patients had a two- to threefold lower ventilation rate of 9%. The two case series from Shenzhen and the province Zhejiang also reported much lower ventilation rates of, respectively, 11% and 2% [9,11] (Figure 2). The median duration of ventilation was 9 days (interquartile range: 7–19, n = 13) for non-invasive and 17 days (interquartile range: 12–19, n = 4) for invasive ventilation in the COVID-19 case series described by Chen et al. [5]. In contrast, the median ventilation duration (invasive and non-invasive) in SPP was only 2 days (interquartile range: 1–4, n = 303). The high ventilation rates and the long duration of ventilation (data from one case series) can be attributed to a high rate of acute respiratory distress syndrome (ARDS) among COVID-19 patients. Again, the difference between Hubei (17–20% ARDS) and outside of Hubei (2–4% ARDS) is striking. However, ARDS was observed in only 1% of SPP.\nFigure 2 Reported proportions of patients on ventilation and proportions of patients who were still hospitalised, five COVID-19 case series, China, January–February 2020 (n = 734)\nCOVID-19: coronavirus disease.\nGrey line: proportion of ventilation in pneumonia sentinel patients. Data from five COVID-19 series [5,6,9-11]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T74","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T75","span":{"begin":12,"end":136},"obj":"Sentence"},{"id":"T76","span":{"begin":137,"end":216},"obj":"Sentence"},{"id":"T77","span":{"begin":217,"end":367},"obj":"Sentence"},{"id":"T78","span":{"begin":368,"end":435},"obj":"Sentence"},{"id":"T79","span":{"begin":436,"end":500},"obj":"Sentence"},{"id":"T80","span":{"begin":501,"end":597},"obj":"Sentence"},{"id":"T81","span":{"begin":598,"end":715},"obj":"Sentence"},{"id":"T82","span":{"begin":716,"end":730},"obj":"Sentence"},{"id":"T83","span":{"begin":731,"end":926},"obj":"Sentence"},{"id":"T84","span":{"begin":927,"end":1022},"obj":"Sentence"},{"id":"T85","span":{"begin":1023,"end":1068},"obj":"Sentence"},{"id":"T86","span":{"begin":1069,"end":1249},"obj":"Sentence"},{"id":"T87","span":{"begin":1250,"end":1280},"obj":"Sentence"},{"id":"T88","span":{"begin":1281,"end":1349},"obj":"Sentence"},{"id":"T89","span":{"begin":1350,"end":1392},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ventilation\nThree case series from the province Hubei described a high rate of cases who needed ventilation (20%, 23% and 25%) [5,6,10]. German pneumonia patients had a two- to threefold lower ventilation rate of 9%. The two case series from Shenzhen and the province Zhejiang also reported much lower ventilation rates of, respectively, 11% and 2% [9,11] (Figure 2). The median duration of ventilation was 9 days (interquartile range: 7–19, n = 13) for non-invasive and 17 days (interquartile range: 12–19, n = 4) for invasive ventilation in the COVID-19 case series described by Chen et al. [5]. In contrast, the median ventilation duration (invasive and non-invasive) in SPP was only 2 days (interquartile range: 1–4, n = 303). The high ventilation rates and the long duration of ventilation (data from one case series) can be attributed to a high rate of acute respiratory distress syndrome (ARDS) among COVID-19 patients. Again, the difference between Hubei (17–20% ARDS) and outside of Hubei (2–4% ARDS) is striking. However, ARDS was observed in only 1% of SPP.\nFigure 2 Reported proportions of patients on ventilation and proportions of patients who were still hospitalised, five COVID-19 case series, China, January–February 2020 (n = 734)\nCOVID-19: coronavirus disease.\nGrey line: proportion of ventilation in pneumonia sentinel patients. Data from five COVID-19 series [5,6,9-11]."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T22","span":{"begin":144,"end":153},"obj":"Phenotype"},{"id":"T23","span":{"begin":865,"end":885},"obj":"Phenotype"},{"id":"T24","span":{"begin":1321,"end":1330},"obj":"Phenotype"}],"attributes":[{"id":"A22","pred":"hp_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A24","pred":"hp_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Ventilation\nThree case series from the province Hubei described a high rate of cases who needed ventilation (20%, 23% and 25%) [5,6,10]. German pneumonia patients had a two- to threefold lower ventilation rate of 9%. The two case series from Shenzhen and the province Zhejiang also reported much lower ventilation rates of, respectively, 11% and 2% [9,11] (Figure 2). The median duration of ventilation was 9 days (interquartile range: 7–19, n = 13) for non-invasive and 17 days (interquartile range: 12–19, n = 4) for invasive ventilation in the COVID-19 case series described by Chen et al. [5]. In contrast, the median ventilation duration (invasive and non-invasive) in SPP was only 2 days (interquartile range: 1–4, n = 303). The high ventilation rates and the long duration of ventilation (data from one case series) can be attributed to a high rate of acute respiratory distress syndrome (ARDS) among COVID-19 patients. Again, the difference between Hubei (17–20% ARDS) and outside of Hubei (2–4% ARDS) is striking. However, ARDS was observed in only 1% of SPP.\nFigure 2 Reported proportions of patients on ventilation and proportions of patients who were still hospitalised, five COVID-19 case series, China, January–February 2020 (n = 734)\nCOVID-19: coronavirus disease.\nGrey line: proportion of ventilation in pneumonia sentinel patients. Data from five COVID-19 series [5,6,9-11]."}
2_test
{"project":"2_test","denotations":[{"id":"32186278-32112886-29336356","span":{"begin":128,"end":129},"obj":"32112886"},{"id":"32186278-32075786-29336357","span":{"begin":132,"end":134},"obj":"32075786"},{"id":"32186278-32404696-29336358","span":{"begin":350,"end":351},"obj":"32404696"},{"id":"32186278-32112886-29336359","span":{"begin":594,"end":595},"obj":"32112886"},{"id":"32186278-32112886-29336360","span":{"begin":1382,"end":1383},"obj":"32112886"},{"id":"32186278-32404696-29336361","span":{"begin":1386,"end":1387},"obj":"32404696"},{"id":"32186278-32075786-29336361","span":{"begin":1386,"end":1387},"obj":"32075786"}],"text":"Ventilation\nThree case series from the province Hubei described a high rate of cases who needed ventilation (20%, 23% and 25%) [5,6,10]. German pneumonia patients had a two- to threefold lower ventilation rate of 9%. The two case series from Shenzhen and the province Zhejiang also reported much lower ventilation rates of, respectively, 11% and 2% [9,11] (Figure 2). The median duration of ventilation was 9 days (interquartile range: 7–19, n = 13) for non-invasive and 17 days (interquartile range: 12–19, n = 4) for invasive ventilation in the COVID-19 case series described by Chen et al. [5]. In contrast, the median ventilation duration (invasive and non-invasive) in SPP was only 2 days (interquartile range: 1–4, n = 303). The high ventilation rates and the long duration of ventilation (data from one case series) can be attributed to a high rate of acute respiratory distress syndrome (ARDS) among COVID-19 patients. Again, the difference between Hubei (17–20% ARDS) and outside of Hubei (2–4% ARDS) is striking. However, ARDS was observed in only 1% of SPP.\nFigure 2 Reported proportions of patients on ventilation and proportions of patients who were still hospitalised, five COVID-19 case series, China, January–February 2020 (n = 734)\nCOVID-19: coronavirus disease.\nGrey line: proportion of ventilation in pneumonia sentinel patients. Data from five COVID-19 series [5,6,9-11]."}
MyTest
{"project":"MyTest","denotations":[{"id":"32186278-32112886-29336356","span":{"begin":128,"end":129},"obj":"32112886"},{"id":"32186278-32075786-29336357","span":{"begin":132,"end":134},"obj":"32075786"},{"id":"32186278-32404696-29336358","span":{"begin":350,"end":351},"obj":"32404696"},{"id":"32186278-32112886-29336359","span":{"begin":594,"end":595},"obj":"32112886"},{"id":"32186278-32112886-29336360","span":{"begin":1382,"end":1383},"obj":"32112886"},{"id":"32186278-32404696-29336361","span":{"begin":1386,"end":1387},"obj":"32404696"},{"id":"32186278-32075786-29336361","span":{"begin":1386,"end":1387},"obj":"32075786"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Ventilation\nThree case series from the province Hubei described a high rate of cases who needed ventilation (20%, 23% and 25%) [5,6,10]. German pneumonia patients had a two- to threefold lower ventilation rate of 9%. The two case series from Shenzhen and the province Zhejiang also reported much lower ventilation rates of, respectively, 11% and 2% [9,11] (Figure 2). The median duration of ventilation was 9 days (interquartile range: 7–19, n = 13) for non-invasive and 17 days (interquartile range: 12–19, n = 4) for invasive ventilation in the COVID-19 case series described by Chen et al. [5]. In contrast, the median ventilation duration (invasive and non-invasive) in SPP was only 2 days (interquartile range: 1–4, n = 303). The high ventilation rates and the long duration of ventilation (data from one case series) can be attributed to a high rate of acute respiratory distress syndrome (ARDS) among COVID-19 patients. Again, the difference between Hubei (17–20% ARDS) and outside of Hubei (2–4% ARDS) is striking. However, ARDS was observed in only 1% of SPP.\nFigure 2 Reported proportions of patients on ventilation and proportions of patients who were still hospitalised, five COVID-19 case series, China, January–February 2020 (n = 734)\nCOVID-19: coronavirus disease.\nGrey line: proportion of ventilation in pneumonia sentinel patients. Data from five COVID-19 series [5,6,9-11]."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"174","span":{"begin":154,"end":162},"obj":"Species"},{"id":"175","span":{"begin":917,"end":925},"obj":"Species"},{"id":"176","span":{"begin":144,"end":153},"obj":"Disease"},{"id":"177","span":{"begin":547,"end":555},"obj":"Disease"},{"id":"178","span":{"begin":859,"end":894},"obj":"Disease"},{"id":"179","span":{"begin":896,"end":900},"obj":"Disease"},{"id":"180","span":{"begin":908,"end":916},"obj":"Disease"},{"id":"181","span":{"begin":971,"end":975},"obj":"Disease"},{"id":"182","span":{"begin":1004,"end":1008},"obj":"Disease"},{"id":"183","span":{"begin":1032,"end":1036},"obj":"Disease"},{"id":"187","span":{"begin":1103,"end":1111},"obj":"Species"},{"id":"188","span":{"begin":1146,"end":1154},"obj":"Species"},{"id":"189","span":{"begin":1189,"end":1197},"obj":"Disease"},{"id":"191","span":{"begin":1260,"end":1279},"obj":"Disease"},{"id":"195","span":{"begin":1340,"end":1348},"obj":"Species"},{"id":"196","span":{"begin":1321,"end":1330},"obj":"Disease"},{"id":"197","span":{"begin":1365,"end":1373},"obj":"Disease"}],"attributes":[{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"Tax:9606"},{"id":"A175","pred":"tao:has_database_id","subj":"175","obj":"Tax:9606"},{"id":"A176","pred":"tao:has_database_id","subj":"176","obj":"MESH:D011014"},{"id":"A177","pred":"tao:has_database_id","subj":"177","obj":"MESH:C000657245"},{"id":"A178","pred":"tao:has_database_id","subj":"178","obj":"MESH:D012128"},{"id":"A179","pred":"tao:has_database_id","subj":"179","obj":"MESH:D012128"},{"id":"A180","pred":"tao:has_database_id","subj":"180","obj":"MESH:C000657245"},{"id":"A181","pred":"tao:has_database_id","subj":"181","obj":"MESH:D012128"},{"id":"A182","pred":"tao:has_database_id","subj":"182","obj":"MESH:D012128"},{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"MESH:D012128"},{"id":"A187","pred":"tao:has_database_id","subj":"187","obj":"Tax:9606"},{"id":"A188","pred":"tao:has_database_id","subj":"188","obj":"Tax:9606"},{"id":"A189","pred":"tao:has_database_id","subj":"189","obj":"MESH:C000657245"},{"id":"A191","pred":"tao:has_database_id","subj":"191","obj":"MESH:D018352"},{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"Tax:9606"},{"id":"A196","pred":"tao:has_database_id","subj":"196","obj":"MESH:D011014"},{"id":"A197","pred":"tao:has_database_id","subj":"197","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ventilation\nThree case series from the province Hubei described a high rate of cases who needed ventilation (20%, 23% and 25%) [5,6,10]. German pneumonia patients had a two- to threefold lower ventilation rate of 9%. The two case series from Shenzhen and the province Zhejiang also reported much lower ventilation rates of, respectively, 11% and 2% [9,11] (Figure 2). The median duration of ventilation was 9 days (interquartile range: 7–19, n = 13) for non-invasive and 17 days (interquartile range: 12–19, n = 4) for invasive ventilation in the COVID-19 case series described by Chen et al. [5]. In contrast, the median ventilation duration (invasive and non-invasive) in SPP was only 2 days (interquartile range: 1–4, n = 303). The high ventilation rates and the long duration of ventilation (data from one case series) can be attributed to a high rate of acute respiratory distress syndrome (ARDS) among COVID-19 patients. Again, the difference between Hubei (17–20% ARDS) and outside of Hubei (2–4% ARDS) is striking. However, ARDS was observed in only 1% of SPP.\nFigure 2 Reported proportions of patients on ventilation and proportions of patients who were still hospitalised, five COVID-19 case series, China, January–February 2020 (n = 734)\nCOVID-19: coronavirus disease.\nGrey line: proportion of ventilation in pneumonia sentinel patients. Data from five COVID-19 series [5,6,9-11]."}